{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T21:07:32Z","timestamp":1775423252837,"version":"3.50.1"},"reference-count":46,"publisher":"Akademiai Kiado Zrt.","issue":"23","license":[{"start":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T00:00:00Z","timestamp":1654387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,6,5]]},"abstract":"<jats:p>Az eml\u0151tumorhoz t\u00e1rsul\u00f3 lymphoedema kialakul\u00e1sa jelent\u0151s \u00e9letmin\u0151s\u00e9g-roml\u00e1ssal \u00e9s\n                    sz\u00f6v\u0151dm\u00e9nyekkel j\u00e1rhat. Kialakul\u00e1s\u00e1ban a seb\u00e9szeti beavatkoz\u00e1s mellett szerepet\n                    j\u00e1tszik a kombin\u00e1lt ter\u00e1pia \u2013 sug\u00e1rkezel\u00e9s, kemoter\u00e1pia, endokrin ter\u00e1pia \u2013 \u00e9s\n                    egy\u00e9b olyan hat\u00e1sok is, melyek a nyirokfunkci\u00f3 tov\u00e1bbi k\u00e1rosod\u00e1s\u00e1t id\u00e9zik el\u0151\n                    (p\u00e9ld\u00e1ul s\u00e9r\u00fcl\u00e9s, fert\u0151z\u00e9s, gyullad\u00e1s vagy sziszt\u00e9m\u00e1s betegs\u00e9g). Az eml\u0151tumorhoz\n                    t\u00e1rsul\u00f3 lymphoedema a daganat kezel\u00e9se ut\u00e1n t\u00f6bbnyire nem azonnal jelentkezik,\n                    ak\u00e1r \u00e9vekkel k\u00e9s\u0151bb aktiv\u00e1l\u00f3dhat, ez\u00e9rt k\u00fcl\u00f6n\u00f6sen fontos az onkol\u00f3giai gondoz\u00e1s\n                    r\u00e9szek\u00e9nt a nyirokoedema sz\u0171r\u00e9se az id\u0151ben t\u00f6rt\u00e9n\u0151 diagnosztiz\u00e1l\u00e1s \u00e9s a\n                    megfelel\u0151 kezel\u00e9s \u00e9rdek\u00e9ben. A nagy rizik\u00f3j\u00fa betegcsoportokban a szubklinikai\n                    vizeny\u0151 korai \u00e9szlel\u00e9s\u00e9re ir\u00e1nyul\u00f3 prospekt\u00edv surveillance program jav\u00edthatja az\n                    \u00e9letmin\u0151s\u00e9get. Jelenleg az eml\u0151tumorhoz t\u00e1rsul\u00f3 lymphoedem\u00e1ban els\u0151k\u00e9nt komplex\n                    fizioter\u00e1pi\u00e1s kezel\u00e9s javasolt, amely a diagn\u00f3zis ut\u00e1n min\u00e9l hamarabb\n                    elkezdend\u0151. Az onkol\u00f3giai rehabilit\u00e1ci\u00f3 keret\u00e9ben a korai kezel\u00e9s ut\u00e1n a betegek\n                    \u00e9lethosszig tart\u00f3 gondoz\u00e1sa sz\u00fcks\u00e9ges. \u00c1ttekint\u00e9s\u00fcnkben bemutatjuk az\n                    eml\u0151tumorhoz t\u00e1rsul\u00f3 lymphoedema patofiziol\u00f3gi\u00e1j\u00e1t, konzervat\u00edv kezel\u00e9s\u00e9t \u00e9s a\n                    ter\u00e1pia \u00faj ir\u00e1nyait. Orv Hetil. 2022; 163(23): 902\u2013910.<\/jats:p>","DOI":"10.1556\/650.2022.32468","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T08:08:37Z","timestamp":1656922117000},"page":"902-910","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":3,"title":["Eml\u0151tumorhoz t\u00e1rsul\u00f3 lymphoedema \u00e9s kezel\u00e9se"],"prefix":"10.1556","volume":"163","author":[{"given":"Anna","family":"Horv\u00e1th","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika, Onkol\u00f3giai R\u00e9szleg Budapest, Szentkir\u00e1lyi u. 46., 1088 Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"R\u00e9dling","sequence":"additional","affiliation":[{"name":"D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Orsz\u00e1gos Hematol\u00f3giai \u00e9s Infektol\u00f3giai Int\u00e9zet, B\u0151rgy\u00f3gy\u00e1szati Szakrendel\u0151 \u00e9s Gondoz\u00f3 Budapest Magyarorsz\u00e1g"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"1 Alitalo","year":"2011","unstructured":"1 Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011; 17: 1371-1380.","journal-title":"Nat Med"},{"key":"ref1","unstructured":"2 Bittar S, Simman R, Lurie F. Lymphedema: a practical approach and clinical update. Wounds 2020; 32: 86-92."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"3 DiSipio","year":"2013","unstructured":"3 DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013; 14: 500-515.","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.19.02896","article-title":"Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment","volume":"38","author":"4 McLaughlin","year":"2020","unstructured":"4 McLaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol. 2020; 38: 2341-2350.","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5 Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg. 2014; 134: 154e-160e.","DOI":"10.1097\/PRS.0000000000000268"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.119.14636","article-title":"Increased blood pressure causes lymphatic endothelial dysfunction via oxidative stress in spontaneously hypertensive rats","volume":"76","author":"6 Mukohda","year":"2020","unstructured":"6 Mukohda M, Mizuno R, Ozaki H. Increased blood pressure causes lymphatic endothelial dysfunction via oxidative stress in spontaneously hypertensive rats. Hypertension 2020; 76: 598-606.","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7 Rupp J, Hadamitzky C, Henkenberens C, et al. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast cancer. A long-term observation. Radiat Oncol. 2019; 14: 39.","DOI":"10.1186\/s13014-019-1243-y"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8 He L, Qu H, Wu Q, et al. Lymphedema in survivors of breast cancer. Oncol Lett. 2020; 19: 2085-2096.","DOI":"10.3892\/ol.2020.11307"},{"key":"ref8","unstructured":"9 Horv\u00e1th A, T\u00f3th \u00c9K, Gr\u00e1f L, et al. Frequency of upper limb lymphedema diagnosed in a population of those admitted to an oncology outpatient clinic at the Department of Internal Medicine and Hematology between 2020 and 2021. [2020 \u00e9s 2021 k\u00f6z\u00f6tt a Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika egy onkol\u00f3giai ambulanci\u00e1j\u00e1n megjelentek popul\u00e1ci\u00f3j\u00e1ban diagnosztiz\u00e1lt fels\u0151 v\u00e9gtagi nyirok\u00f6d\u00e9ma gyakoris\u00e1ga.] Magyar Onkol\u00f3gusok T\u00e1rsas\u00e1ga XXXIV. Kongresszusa, Szeged, 2021. november 11-13. POSZTER\u00c1LLV\u00c1NY 2. Eml\u0151daganatok, Gastrointestinalis onkol\u00f3gia - P-06-EM. [Hungarian]"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1200\/JCO.2008.16.4731","article-title":"Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study","volume":"26","author":"10 Ahmed","year":"2008","unstructured":"10 Ahmed RL, Prizment A, Lazovich D, et al. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol. 2008; 26: 5689-5696.","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaad.2017.03.022","article-title":"Lymphedema: pathophysiology and clinical manifestations","volume":"77","author":"Grada AA","year":"2017","unstructured":"11 Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol. 2017; 77: 1009-1020.","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/lrb.2013.0037","article-title":"Clinical features of docetaxel chemotherapy-related lymphedema","volume":"12","author":"12 Park","year":"2014","unstructured":"12 Park SI, Jeon WH, Jeung HJ, et al. Clinical features of docetaxel chemotherapy-related lymphedema. Lymphat Res Biol. 2014; 12: 197-202.","journal-title":"Lymphat Res Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bjpt.2020.05.009","article-title":"Comparing the experience of individuals with primary and secondary lymphoedema: a qualitative study","volume":"25","author":"R\u00edo-Gonz\u00e1lez \u00c1","year":"2021","unstructured":"13 R\u00edo-Gonz\u00e1lez \u00c1, Molina-Rueda F, Palacios-Ce\u00f1a D, et al. Comparing the experience of individuals with primary and secondary lymphoedema: a qualitative study. Braz J Phys Ther. 2021; 25: 203-213.","journal-title":"Braz J Phys Ther"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14 Shaitelman SF, Chiang YJ, Griffin KD, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017; 162: 201-215. [Erratum: Breast Cancer Res Treat. 2017; 162: 217.]","DOI":"10.1007\/s10549-016-4089-0"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/ATVBAHA.118.310997","article-title":"Lymphatic vasculature requires estrogen receptor-\u03b1 signaling to protect from lymphedema","volume":"38","author":"15 Morfoisse","year":"2018","unstructured":"15 Morfoisse F, Tatin F, Chaput B, et al. Lymphatic vasculature requires estrogen receptor-\u03b1 signaling to protect from lymphedema. Arterioscler Thromb Vasc Biol. 2018; 38: 1346-1357.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11764-014-0416-9","article-title":"Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors","volume":"9","author":"16 Das","year":"2015","unstructured":"16 Das N, Baumgartner RN, Riley EC, et al. Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. J Cancer Surviv. 2015; 9: 422-430.","journal-title":"J Cancer Surviv"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41581-021-00438-y","article-title":"The lymphatics in kidney health and disease","volume":"17","author":"17 Donnan","year":"2021","unstructured":"17 Donnan MD, Kenig-Kozlovsky Y, Quaggin SE. The lymphatics in kidney health and disease. Nat Rev Nephrol. 2021; 17: 655-675.","journal-title":"Nat Rev Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13058-020-01337-z","article-title":"Incidence of hypothyroidism after treatment for breast cancer - a Danish matched cohort study","volume":"22","author":"18 Falstie-Jensen","year":"2020","unstructured":"18 Falstie-Jensen AM, Esen B\u00d6, Kj\u00e6rsgaard A, et al. Incidence of hypothyroidism after treatment for breast cancer - a Danish matched cohort study. Breast Cancer Res. 2020; 22: 106.","journal-title":"Breast Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19 Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology 2020; 53: 3-19.","DOI":"10.2458\/lymph.4649"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20 Wenczl E. Management of secondary lymphedema in patients with cancer. [Daganatos betegekben kialakult m\u00e1sodlagos nyirok\u00f6d\u00e9ma ell\u00e1t\u00e1sa.] Orv Hetil. 2016; 157: 488-494. [Hungarian]","DOI":"10.1556\/650.2016.30390"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.rpor.2020.09.006","article-title":"Stewart-Treves syndrome: case report and literature review","volume":"25","author":"21 Vojt\u00ed\u0161ek","year":"2020","unstructured":"21 Vojt\u00ed\u0161ek R, Sukovsk\u00e1 E, Kylarov\u00e1 M, et al. Stewart-Treves syndrome: case report and literature review. Rep Pract Oncol Radiother. 2020; 25: 934-938.","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.01.001","article-title":"Standardized method for quantification of developing lymphedema in patients treated for breast cancer","volume":"79","author":"22 Ancukiewicz","year":"2011","unstructured":"22 Ancukiewicz M, Russell TA, Otoole J, et al. Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2011; 79: 1436-1443.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Brunelle CL, Barrio AV, Shaitelman SF, et al. On \"Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association.\" Levenhagen K, Davies C, Perdomo M, et al. Phys Ther. 2017; 97: 729-745. Phys Ther. 2018; 98: 277-281.","DOI":"10.1093\/ptj\/pzy004"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/ptj\/pzaa087","article-title":"Interventions for breast cancer-related lymphedema: clinical practice guideline from the Academy of Oncologic Physical Therapy of APTA","volume":"100","author":"24 Davies","year":"2020","unstructured":"24 Davies C, Levenhagen K, Ryans K, et al. Interventions for breast cancer-related lymphedema: clinical practice guideline from the Academy of Oncologic Physical Therapy of APTA. Phys Ther. 2020; 100: 1163-1179.","journal-title":"Phys Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1245\/s10434-018-6601-8","article-title":"Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions","volume":"25","author":"25 Kilgore","year":"2018","unstructured":"25 Kilgore LJ, Korentager SS, Hangge AN, et al. Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol. 2018; 25: 2948-2952.","journal-title":"Ann Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/mhealth-19-218","article-title":"Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital","volume":"7","author":"26 Havens","year":"2021","unstructured":"26 Havens LM, Brunelle CL, Gillespie TC, et al. Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital. Mhealth 2021; 7: 11.","journal-title":"Mhealth"},{"key":"ref26","unstructured":"27 Dar\u00f3czy J. Lymphedema - The most common disease of the lymphatic system - The care of lymphedema patients. [Nyirokoedema - A nyirokrendszer leggyakoribb betegs\u00e9ge - A nyirok\u00f6d\u00e9m\u00e1s beteg ell\u00e1t\u00e1sa.] K.U.K. Kiad\u00f3, Budapest, 2009; pp: 42-83. [Hungarian]"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28 Update on bioelectric impedance analysis for upper-quadrant lymphedema from the authors of \"Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association\". Levenhagen K, Davies C, Perdomo M, et al. Phys Ther. 2017; 97: 729-745. Phys Ther. 2018; 98: 821.","DOI":"10.1093\/ptj\/pzy096"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29 Ryans K, Perdomo M, Davies CC, et al. Rehabilitation interventions for the management of breast cancer-related lymphedema: developing a patient-centered, evidence-based plan of care throughout survivorship. J Cancer Surviv. 2021 Jan 22. . [Epub ahead of print]","DOI":"10.1007\/s11764-021-00991-2"},{"key":"ref29","unstructured":"Crossref"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/COC.0000000000000355","article-title":"Review of treatment for breast cancer-related lymphedema: paradigms for clinical practice","volume":"41","author":"30 Smile","year":"2018","unstructured":"30 Smile TD, Tendulkar R, Schwarz G, et al. Review of treatment for breast cancer-related lymphedema: paradigms for clinical practice. Am J Clin Oncol. 2018; 41: 178-190.","journal-title":"Am J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1177\/0269215518821785","article-title":"Effectiveness of a precast adjustable compression system compared to multilayered compression bandages in the treatment of breast cancer-related lymphoedema: a randomized, single-blind clinical trial","volume":"33","author":"31 Pujol-Blaya","year":"2019","unstructured":"31 Pujol-Blaya V, Salinas-Huertas S, Catas\u00fas ML, et al. Effectiveness of a precast adjustable compression system compared to multilayered compression bandages in the treatment of breast cancer-related lymphoedema: a randomized, single-blind clinical trial. Clin Rehabil. 2019; 33: 631-641.","journal-title":"Clin Rehabil"},{"key":"ref32","unstructured":"32 Szolnoky G, Lakatos B, Keskeny T, et al. Intermittent pneumatic compression acts synergistically with manual lymphatic drainage in complex decongestive physiotherapy for breast cancer treatment-related lymphedema. Lymphology 2009; 42: 188-194."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1186\/s12885-020-07558-x","article-title":"Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial","volume":"20","author":"33 Mu\u00f1oz-Alcaraz","year":"2020","unstructured":"33 Mu\u00f1oz-Alcaraz MN, P\u00e9rula-de-Torres L\u00c1, Serrano-Merino J, et al. Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial. BMC Cancer 2020; 20: 1074.","journal-title":"BMC Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/09638288.2018.1514663","article-title":"Resistance exercise and breast cancer related lymphedema - a systematic review update","volume":"42","author":"34 Hasenoehrl","year":"2020","unstructured":"34 Hasenoehrl T, Keilani M, Palma S, et al. Resistance exercise and breast cancer related lymphedema - a systematic review update. Disabil Rehabil. 2020; 42: 26-35.","journal-title":"Disabil Rehabil"},{"key":"ref35","unstructured":"35 Kah\u00e1n Z, Sz\u00e1nt\u00f3 I, Moln\u00e1r M, et al. Breast cancer: patient care, rehabilitation, psychooncology [Eml\u0151r\u00e1k: gondoz\u00e1s, rehabilit\u00e1ci\u00f3, pszichoonkol\u00f3gia.] Magy Onkol. 2016; 60: 258-268. [Hungarian]"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"36 Rockson SG, Tian W, Jiang X, et al. Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema. JCI Insight 2018; 3: e123775.","DOI":"10.1172\/jci.insight.123775"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/lrb.2005.3.81","article-title":"Pharmacogenomics: its role in re-establishing coumarin as a treatment for lymphedema","volume":"3","author":"Farinola","year":"2005","unstructured":"37 Farinola, N, Piller N. Pharmacogenomics: its role in re-establishing coumarin as a treatment for lymphedema. Lymphat Res Biol. 2005; 3: 81-86.","journal-title":"Lymphat Res Biol"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"38 Forte AJ, Boczar D, Huayllani MT, et al. Pharmacotherapy agents in lymphedema treatment: a systematic review. Cureus 2019; 11: e6300.","DOI":"10.7759\/cureus.6300"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"39 Badger C, Preston N, Seers K, et al. Benzo-pyrones for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004; 2004: CD003140.","DOI":"10.1002\/14651858.CD003141.pub2"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/dbio.1997.8639","article-title":"VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane","volume":"188","author":"SJ","year":"1997","unstructured":"40 Oh SJ, Jeltsch MM, Birkenh\u00e4ger R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 1997; 188: 96-109.","journal-title":"Dev Biol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1038\/s41467-021-23546-6","article-title":"Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema","volume":"12","author":"41 Sz\u0151ke","year":"2021","unstructured":"41 Sz\u0151ke D, Kov\u00e1cs G, Kemecsei \u00c9, et al. Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema. Nat Commun. 2021; 12: 3460.","journal-title":"Nat Commun"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela T","year":"2010","unstructured":"42 Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010; 140: 460-476.","journal-title":"Cell"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1524-4741.2006.00380.x","article-title":"Octreotide can control lymphorrhea after axillary node dissection in mastectomy operations","volume":"13","author":"43 Mahmoud","year":"2007","unstructured":"43 Mahmoud SA, Abdel-Elah K, Eldesoky AH, et al. Octreotide can control lymphorrhea after axillary node dissection in mastectomy operations. Breast J. 2007; 13: 108-109.","journal-title":"Breast J"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"44 Tzou CJ, Steinbacher J, Czedik-Eysenberg M, et al. Institutionalization of reconstructive lymphedema surgery in Austria. Single center experience. J Surg Oncol. 2020; 121: 91-99.","DOI":"10.1002\/jso.25740"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"12208","DOI":"10.1002\/jcb.28832","article-title":"Melatonin is an appropriate candidate for breast cancer treatment: based on known molecular mechanisms","volume":"120","author":"45 Amin","year":"2019","unstructured":"45 Amin N, Shafabakhsh R, Reiter RJ, et al. Melatonin is an appropriate candidate for breast cancer treatment: based on known molecular mechanisms. J Cell Biochem. 2019; 120: 12208-12215.","journal-title":"J Cell Biochem"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/23\/article-p902.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/23\/article-p902.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/23\/article-p902.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T16:15:53Z","timestamp":1698250553000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/23\/article-p902.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,5]]},"references-count":46,"journal-issue":{"issue":"23"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32468","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,5]]}}}